Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study

Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study

Item

http://www.wikidata.org/entity/Q28236421

Q28236421

about

The PLIN4 variant rs8887 modulates obesity related phenotypes in humans through creation of a novel miR-522 seed site Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management Impact of apolipoprotein A5 variants on statin treatment efficacy Clinical significance of apolipoprotein A5 APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population The association between APOA5 haplotypes and plasma lipids is not modified by energy or fat intake: the Czech HAPIEE study Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene - 1131T>C variant and associations with plasma lipids and lipid peroxidation.Effects of a 3-year dietary intervention on age-related changes in triglyceride and apolipoprotein A-V levels in patients with impaired fasting glucose or new-onset type 2 diabetes as a function of the APOA5 -1131 T > C polymorphism.Nutrigenomics in cardiovascular medicine.A rapid method for determining arachidonic:eicosapentaenoic acid ratios in whole blood lipids: correlation with erythrocyte membrane ratios and validation in a large Italian population of various ages and pathologies.Atherogenic dyslipidemia: cardiovascular risk and dietary intervention Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on ω6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease.Rat chromosome 8 confers protection against dyslipidemia caused by a high-fat/low-carbohydrate diet.Genetics of the Framingham Heart Study population Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach Association of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men.Interactions between dietary n-3 fatty acids and genetic variants and risk of disease A Database of Gene-Environment Interactions Pertaining to Blood Lipid Traits, Cardiovascular Disease and Type 2 Diabetes.Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterol APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial Serum vitamins A and E as modifiers of lipid trait genetics in the National Health and Nutrition Examination Surveys as part of the Population Architecture using Genomics and Epidemiology (PAGE) study Nutrigenomics: a case for the common soil between cardiovascular disease and cancer.Omega-3 fatty acids, polymorphisms and lipid related cardiovascular disease risk factors in the Inuit population Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase.Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.Dyslipidemia in obesity: mechanisms and potential targets Overexpression of apolipoprotein A5 in mice is not protective against body weight gain and aberrant glucose homeostasis.Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia.Genetic variants at the PDZ-interacting domain of the scavenger receptor class B type I interact with diet to influence the risk of metabolic syndrome in obese men and women.Associations between explorative dietary patterns and serum lipid levels and their interactions with ApoA5 and ApoE haplotype in patients with recently diagnosed type 2 diabetes.Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there?Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults.Consumption of whole grains and legumes modulates the genetic effect of the APOA5 -1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes.Nutrigenetics and nutrigenomics of atherosclerosis.Nutrigenetics of the lipoprotein metabolism.Nutritional status, genetic susceptibility, and insulin resistance--important precedents to atherosclerosis.New criteria for supplementation of selected micronutrients in the era of nutrigenetics and nutrigenomics.Nutrigenetics of cholesterol metabolism: observational and dietary intervention studies in the postgenomic era.Detection of gene-environment interactions in a family-based population using SCAD.Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor.

P2860

Q21135510-8E339586-5E8E-4803-8E16-8BB2E8598770 Q26741557-F12DD0A5-9F65-4EF3-B721-722394F7B195 Q28248690-F301AB0D-D3A4-473B-9DA4-0316F88FC43C Q28286349-8D5BCD46-ADA7-4117-A705-40B8B637DF67 Q28302513-44E692A6-5E53-4D31-86CF-DC6FEFD8665F Q28306572-FE8A25DA-A8DC-46F5-8227-BB2BB946C05E Q33293923-C3745588-536B-4C2F-9ACC-0C55FEC6B3D8 Q33574568-AA72BD87-F4F8-44B9-B5FB-ED0701D1519D Q33605821-90D7D045-9D3D-402B-9A5E-D8E30303FE9C Q33711837-A447D2DC-495B-4537-A8C6-3C72A5847252 Q34180234-0AE7EB19-C19D-4A4D-A35D-B988D31C9A31 Q34188057-4969C35B-6AF2-4C70-A495-8A8D86831252 Q34206069-42946A76-506F-44A5-B459-238766FB6665 Q34458072-E41E1319-A6D3-4F13-B9D8-9EF579026BA4 Q35104849-BCD92E41-A6AD-41D2-B603-4BF0F3E5B565 Q35591965-CE244296-0947-44CF-BF18-6D898582B892 Q35598019-92080C03-DBB6-41C1-A15A-B974087F02C8 Q35745829-C08288F4-134C-4BA1-949D-E9285FBC3AC4 Q35907312-CE1F27A8-D48C-4D95-B8C0-37E099427BB0 Q36231656-6C844363-2B07-402A-A39C-4EA5AAAF76EA Q36319853-435780A3-7E52-44FB-86E2-48F08B5EB238 Q36558565-48B05E5C-B9D5-4821-B888-3111721B7B51 Q36805381-4CD46D72-7F27-48FB-BD33-FE4C93EA0958 Q36818981-6DAD2B6E-6781-48B0-846F-D259904F0402 Q36975580-2D042E5B-FAED-4B79-90CC-86AB277FDB68 Q36994072-E3A239DF-404C-4BB7-88C1-5B497DC3AB48 Q37209161-4C288F7D-E325-4EC2-9C2E-305998FECD90 Q37271474-C60CD27A-0E6B-4E9D-B25B-58ED4AA54B48 Q37271503-0109FBE1-99D3-4EAC-8FB1-C5AA67DFBD30 Q37291712-00EF13ED-5F00-49EC-B0BC-BD661E06FB12 Q37401949-E384EA40-9C5F-485A-930B-8D85EE5C927C Q37421221-31089C91-5B2A-4210-82B9-018F36323D04 Q37682045-D5B89D7D-EF7A-4408-AFDB-97A9B83BA320 Q37730893-C896731F-F7D2-43B6-A4BB-2294D4D62B93 Q37961647-0DFC904D-42B3-40CF-BF00-877F2636343D Q38023791-8B3162C7-9CF3-471C-A06F-C87C14E21A68 Q38195644-264493E7-60BE-49C3-AD94-E7AF5570ED58 Q38539222-731B7CBB-81FD-4E66-9267-7E9DF3DFD463 Q38679643-53D6EBDA-5D4B-4245-96BB-FBF731B8BE53 Q38936923-711D0534-548C-4956-BC70-A92D3A17AE6E

P2860

Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study

Item

http://www.wikidata.org/entity/Q28236421

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu